Vyne Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.60

-0.01 (-1.61%)

As of Mar 24, 10:13 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +3,123.6% upside

Low Target $14.75

Average Target $19.49

High Target $26.42

Current Price $0.60

Current
$0.60

Target
$19.49

$14.75 $19.49 avg $26.42

Scenario Analysis

Bear Case

$14.75

2,339.6%

Low target

Base Case

$19.49

+3,123.6%

Avg target

Bull Case

$26.42

+4,269.8%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$1.99

-69.7% from high

52-Week Low

$0.28

+115.5% from low

Target vs 52W High

$19.49

+877.8% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%